Validation of the Combination Gleason Score as an Independent Favorable Prognostic Factor in Prostate Cancer Treated With Dose-Escalated Radiation Therapy.

Quinn, Thomas J; Chapman, Daniel; Parzen, Jacob; Wahl, Daniel R; McNamara, Alyssa; Dess, Robert; Chan, Jason; Feng, Felix; Jackson, William C; Hamstra, Daniel

Quinn, Thomas J; Chapman, Daniel; Parzen, Jacob; Wahl, Daniel R; McNamara, Alyssa; Dess, Robert; Chan, Jason; Feng, Felix; Jackson, William C; Hamstra, Daniel.

Afiliación

Quinn TJ; Beaumont Health, Royal Oak, Michigan. Electronic address: thomas.quinn@beaumont.org.
Chapman D; Henry Ford Health, Detroit, Michigan.
Parzen J; Beaumont Health, Royal Oak, Michigan.
Wahl DR; University of Michigan, Ann Arbor, Michigan.
McNamara A; University of California, San Francisco, California.
Dess R; University of Michigan, Ann Arbor, Michigan.
Chan J; University of Michigan, Ann Arbor, Michigan.
Feng F; University of California, San Francisco, California.
Jackson WC; University of Michigan, Ann Arbor, Michigan.
Hamstra D; Baylor College of Medicine, Houston, Texas.

Pract Radiat Oncol ; 13(2): e166-e175, 2023.

Article en En | MEDLINE | ID: mdl-36503624

Asunto(s)

Neoplasias de la Próstata; Masculino; Humanos; Clasificación del Tumor; Pronóstico; Neoplasias de la Próstata/patología; Antígeno Prostático Específico; Próstata/patología

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Pract Radiat Oncol Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google